Trial Profile

Study on the Effects of Raltegravir (Isentress) on Lipid and Carbohydrate Metabolism and Mitochondrial Function in Healthy Volunteers.

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 27 Feb 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Raltegravir (Primary)
Indications HIV-1 infections
Focus Pharmacodynamics
Acronyms RALMET-VOLHCB

Most Recent Events

02 Apr 2010 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
02 Apr 2010 Actual initiation date (Mar 2010) added as reported by ClinicalTrials.gov.
10 Mar 2010 Planned end date changed from 1 Dec 2009 to 1 Mar 2011 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com